Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers*

Chemokine receptors are presently used as targets for candidate drugs in the frame of inflammatory diseases and human immunodeficiency virus infection. They were shown to dimerize, but the functional relevance of dimerization in terms of drug action remains poorly understood. We reported previously the existence of negative binding cooperativity between the subunits of CCR2/CCR5 heterodimers. In the present study, we extend these observations to heterodimers formed by CCR2 and CXCR4, which are more distantly related. We also show that specific antagonists of one receptor inhibit the binding of chemokines to the other receptor as a consequence of their heterodimerization, both in recombinant cell lines and primary leukocytes. This resulted in a significant functional cross-inhibition in terms of calcium mobilization and chemotaxis. These data demonstrate that chemokine receptor antagonists regulate allosterically the functional properties of receptors on which they do not bind directly, with important implications on the effects of these potential therapeutic agents.

[1]  Mario Mellado,et al.  Chemokine receptor homo‐ or heterodimerization activates distinct signaling pathways , 2001, The EMBO journal.

[2]  S. Swillens,et al.  Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity , 2005, The EMBO journal.

[3]  M. Bouvier,et al.  Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.

[4]  R. Doms,et al.  CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999 .

[5]  F. Wurm,et al.  Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. , 1996, Nucleic acids research.

[6]  Marc Parmentier,et al.  Dimerization of chemokine receptors and its functional consequences. , 2005, Cytokine & growth factor reviews.

[7]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[8]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[9]  T. Williams,et al.  The attraction of chemokines as a target for specific anti‐inflammatory therapy , 2006, British journal of pharmacology.

[10]  C. Martínez-A,et al.  The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  S. Knechtle,et al.  CXCR3‐mediated T‐cell chemotaxis involves ZAP‐70 and is regulated by signalling through the T‐cell receptor , 2007, Immunology.

[12]  Y. Iwasaki,et al.  Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Michel Bouvier,et al.  Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers* , 2005, Journal of Biological Chemistry.

[14]  R. Rabin,et al.  Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. , 1999, Journal of immunology.

[15]  J. Lord,et al.  Persistent Induction of the Chemokine Receptor CXCR4 by TGF-β1 on Synovial T Cells Contributes to Their Accumulation Within the Rheumatoid Synovium1 , 2000, The Journal of Immunology.

[16]  Won-Tak Choi,et al.  Unique Ligand Binding Sites on CXCR4 Probed by a Chemical Biology Approach: Implications for the Design of Selective Human Immunodeficiency Virus Type 1 Inhibitors , 2005, Journal of Virology.

[17]  M. Ratajczak,et al.  SDF-1 alone and in co-operation with HGF regulates biology of human cervical carcinoma cells. , 2006, Folia histochemica et cytobiologica.

[18]  Y. Yashiro‐Ohtani,et al.  The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3 , 2003, Journal of leukocyte biology.

[19]  C. Snyderman,et al.  Chemokine receptors in head and neck cancer: Association with metastatic spread and regulation during chemotherapy , 2006, International journal of cancer.

[20]  Gregory J Babcock,et al.  Ligand-independent Dimerization of CXCR4, a Principal HIV-1 Coreceptor* , 2003, The Journal of Biological Chemistry.

[21]  Ashok Kumar,et al.  CXCR4 physically associates with the T cell receptor to signal in T cells. , 2006, Immunity.

[22]  G. Milligan,et al.  Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function* , 2006, Journal of Biological Chemistry.

[23]  C. Martínez-A,et al.  Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. , 1997, Journal of immunology.

[24]  E. De Clercq,et al.  Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4 , 2002, FEBS letters.

[25]  J. Shaw,et al.  Chemokine blockers--therapeutics in the making? , 2006, Trends in pharmacological sciences.

[26]  A. Levitzki.  Negative co-operativity in clustered receptors as a possible basis for membrane action. , 1974, Journal of theoretical biology.

[27]  I. Charo,et al.  Chemokines in the pathogenesis of vascular disease. , 2004, Circulation research.

[28]  O. Nishimura,et al.  A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Wong,et al.  Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. , 2006, Biochemical pharmacology.

[30]  J. Peacock,et al.  TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: evidence for reciprocal regulation between CXCR4 and the TCR. , 1999, Journal of immunology.

[31]  G Vassart,et al.  Molecular cloning and functional expression of a new human CC-chemokine receptor gene. , 1996, Biochemistry.

[32]  V. Höllt,et al.  CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain. , 2007, Journal of molecular endocrinology.

[33]  M. Parmentier,et al.  Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers , 2006, Molecular Pharmacology.

[34]  M. Parmentier,et al.  Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.

[35]  A. Engel,et al.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.

[36]  D. Graves,et al.  Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. , 1992, Journal of immunology.